Skip to main content
Wockhardt Ltd logo

Wockhardt Ltd — Investor Relations & Filings

Ticker · WOCKPHARMA ISIN · INE049B01025 LEI · 3358001OC2OX7OZAHZ33 BSE.NS Manufacturing
Open in API
Filings indexed 861 across all filing types
Latest filing 2024-03-28 Regulatory Filings
Country IN India
Listing BSE.NS WOCKPHARMA

About Wockhardt Ltd

https://www.wockhardt.com/

Wockhardt Ltd is a research-driven global organization focused on the development and manufacturing of formulations, biopharmaceuticals, and active pharmaceutical ingredients (APIs). The company maintains a specialized focus on drug discovery, particularly in the field of anti-infectives and New Chemical Entities (NCEs) aimed at addressing antimicrobial resistance. Its therapeutic portfolio encompasses diverse areas such as diabetes, nephrology, cardiology, and respiratory health. With a strong emphasis on research and development, the company operates multiple manufacturing facilities that comply with international regulatory standards. Wockhardt provides medical solutions across various international markets, utilizing its expertise in complex chemistry and biotechnology to address unmet clinical needs.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notification from the company to stock exchanges about the closure of the trading window ahead of the announcement of audited financial results for the fiscal year ending March 31, 2024. It does not contain any financial data, results, or detailed report content. Instead, it informs about the trading restrictions in compliance with the company's code of conduct. The document length is short (1275 characters) and serves as an announcement rather than a report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-03-28 English
Allotment of Securities
Capital/Financing Update Classification · 95% confidence The document is an official communication from Wockhardt Limited to stock exchanges regarding the outcome of a Qualified Institutions Placement (QIP) of equity shares. It details the allotment of shares, the increase in paid-up capital, the issue price, and includes annexures listing allottees and regulatory disclosures as per SEBI regulations. The content focuses on capital raising activities, share allotment, and compliance with securities regulations. There are no financial statements or comprehensive financial performance data, so it is not an Annual Report or Interim Report. It is not a simple announcement of a report publication but a substantive update on financing activity. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2024-03-26 English
Outcome of Board Meeting
Capital/Financing Update Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the outcome of a Capital Raising Committee meeting. It details the closure of a Qualified Institutions Placement (QIP) of equity shares, the allocation of shares, the issue price, and the approval of a placement document. The letter references regulatory compliance under SEBI ICDR Regulations and the Companies Act. The content focuses on the announcement of a capital raising event and the allocation of shares, rather than presenting financial statements or detailed financial performance. The document length is 3436 characters, which is relatively short and primarily serves as an announcement of the capital raising outcome and related approvals. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2024-03-26 English
Board Meeting — Wockhardt Limited has informed the Exchange about Board Meeting to be held on 26-Mar-2024 to consider Fund raising.
Regulatory Filings
2024-03-20 English
Board Meeting — Fund Raising
Capital/Financing Update Classification · 95% confidence The document is a letter from Wockhardt Limited addressed to stock exchanges regarding a qualified institutions placement (QIP) of equity shares. It mentions regulatory compliance under SEBI Listing Regulations and SEBI ICDR Regulations, and informs about a meeting to determine the issue price of shares. The content is an announcement about a capital raising activity and prior intimation for price determination, not a full financial report or detailed financial data. The document length is short (2289 characters) and it serves as a notification rather than a report. Therefore, it fits best under Capital/Financing Update (CAP).
2024-03-20 English
Qualified Institutional Placement
Capital/Financing Update Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding a qualified institutions placement (QIP) of equity shares by Wockhardt Limited. It details the outcome of a Capital Raising Committee meeting, including approval of the issue opening, floor price, and preliminary placement document. The document references regulatory provisions under SEBI ICDR Regulations and Companies Act, indicating compliance and disclosure requirements. The content focuses on capital raising activities and approvals rather than presenting financial results or detailed financial statements. The document length is 3570 characters, which is relatively short and primarily an announcement of capital raising activity and related approvals. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2024-03-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.